CIBC Asset Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
CIBC Asset Management's NVS Position: Q3 2026 in Review
CIBC Asset Management increased its Novartis (NVS) stake by 7.5% in Q3 2026, buying an estimated $321K and bringing the position to 30,200 shares worth $4.28M. The position accounts for 0.01% of the portfolio, ranked #539.
CIBC Asset Management first reported a position in NVS in Q3 2017 and has held it in 26 quarters since. The position peaked at $6.6M in Q1 2019. 1,560 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- CIBC Asset Management held 30,200 shares of Novartis worth $4.28M as of Q3 2026.
- CIBC Asset Management bought 2,116 Novartis shares in Q3 2026, an estimated $321K.
- Novartis made up 0.01% of CIBC Asset Management's portfolio in Q3 2026, its #539 holding.
- CIBC Asset Management first reported a position in Novartis in Q3 2017 and has held it in 26 quarters since.
- CIBC Asset Management's Novartis position peaked at $6.6M in Q1 2019.
- 1,560 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on CIBC Asset Management's 13F filing for Q3 2026, filed 5 Nov 2026.